Safety and Performance of Hemostatic Powders

References

• Morrison CA. The prehospital treatment of the bleeding patient--dare to dream. J Surg Res. 2013;180(2):246–247. doi:10.1016/j.jss.2011.12.022
   PubMed Web of Science ®Google Scholar
• Chambers JA, Seastedt K, Krell R, et al. “Stop the bleed”: a U.S. military installation’s model for implementation of a rapid hemorrhage control program. Mil Med. 2019;184(3–4):67–71. doi:10.1093/milmed/usy185
   PubMed Web of Science ®Google Scholar
• Holcomb JB, Del Junco DJ, Fox EE, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148(2):127–136. doi:10.1001/2013.jamasurg.387
   PubMed Web of Science ®Google Scholar
• Mutschler M, Nienaber U, Brockamp T, et al. Renaissance of base deficit for the initial assessment of trauma patients: a base deficit-based classification for hypovolemic shock developed on data from 16,305 patients derived from the TraumaRegister DGU®. Crit Care. 2013;17(2):R42. doi:10.1186/cc12555
   PubMed Web of Science ®Google Scholar
• Haapio E, Kinnunen I, Airaksinen JKE, et al. Determinants of re-operation for bleeding in head and neck cancer surgery. J Laryngol Otol. 2018;132(4):336–340. doi:10.1017/S0022215118000294
   PubMed Web of Science ®Google Scholar
• Shah A, Palmer AJR, Klein AA. Strategies to minimize intraoperative blood loss during major surgery. BJS Br J Surg. 2020;107(2):e26–e38. doi:10.1002/bjs.11393
   PubMed Web of Science ®Google Scholar
• Liu L, Mei J, He J, et al. International expert consensus on the management of bleeding during VATS lung surgery. Ann Transl Med. 2019;7(23):712. doi:10.21037/atm.2019.11.142
   PubMed Web of Science ®Google Scholar
• Sung YK, Lee DR, Chung DJ. Advances in the development of hemostatic biomaterials for medical application. Biomater Res. 2021;25:37. doi:10.1186/s40824-021-00239-1
   PubMedGoogle Scholar
• Kheirabadi B. Evaluation of topical hemostatic agents for combat wound treatment. US Army Med Dep J. 2011;2011:25–37.
   Google Scholar
• Zhong Y, Hu H, Min N, et al. Application and outlook of topical hemostatic materials: a narrative review. Ann Transl Med. 2021;9(7):577. doi:10.21037/atm-20-7160
   PubMed Web of Science ®Google Scholar
• Nouri S, Sharif MR, Afzali H, et al. The advantages and disadvantages of methods used to control liver bleeding: a review. Trauma Mon. 2015;20(4):e28088. doi:10.5812/traumamon.28088
   PubMedGoogle Scholar
• Szymanski L, Golaszewska K, Wiatrowska A, et al. ISO 10993 biological evaluation of novel hemostatic powder – 4SEAL®. Biomater Res. 2022;26(1):12. doi:10.1186/s40824-022-00258-6
   PubMedGoogle Scholar
• Anonymous. ISO 10993-12:2021(En), biological evaluation of medical devices — part 12: sample preparation and reference materials. Available from: https://www.iso.org/obp/ui/#iso:std:iso:10993:-12:ed-5:v1:en. Accessed January 13, 2022.
   Google Scholar
• Anonymous. ISO 10993-5:2009(En), biological evaluation of medical devices — part 5: tests for in vitro cytotoxicity. Available from: https://www.iso.org/obp/ui/#iso:std:iso:10993:-5:ed-3:v1:en. Accessed January 13, 2022.
   Google Scholar
• Ji X, Xing C, Shi X. Modified starch material of biocompatible hemostasis; 2013.
   Google Scholar
• Anonymous. Bacterial Endotoxins. USP. Available from: https://www.usp.org/harmonization-standards/pdg/general-methods/bacterial-endotoxins. Accessed January 13, 2022.
   Google Scholar
• Räägel H, Turley A, Fish T, et al. Medical device industry approaches for addressing sources of failing cytotoxicity scores. Biomed Instrum Technol. 2021;55(2):69–84. doi:10.2345/0890-8205-55.2.69
   PubMedGoogle Scholar
• Li W, Zhou J, Xu Y. Study of the in vitro cytotoxicity testing of medical devices. Biomed Rep. 2015;3(5):617–620. doi:10.3892/br.2015.481
   PubMed Web of Science ®Google Scholar
• Liu X, Rodeheaver DP, White JC, et al. A comparison of in vitro cytotoxicity assays in medical device regulatory studies. Regul Toxicol Pharmacol RTP. 2018;97:24–32. doi:10.1016/j.yrtph.2018.06.003
   PubMed Web of Science ®Google Scholar
• Manouchehrian O, Ramos M, Bachiller S, et al. Acute systemic LPS-exposure impairs perivascular CSF distribution in mice. J Neuroinflammation. 2021;18(1):34. doi:10.1186/s12974-021-02082-6
   PubMed Web of Science ®Google Scholar
• Erickson MA, Hartvigson PE, Morofuji Y, et al. Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood–brain barrier. J Neuroinflammation. 2012;9:150. doi:10.1186/1742-2094-9-150
   PubMed Web of Science ®Google Scholar
• Research C for DE and Guidance for Industry. Pyrogen and endotoxins testing: questions and answers. FDA; 2019. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-pyrogen-and-endotoxins-testing-questions-and-answers. Accessed August 18, 2021.
   Google Scholar
• Bustamante-Balén M, Plumé G. Role of hemostatic powders in the endoscopic management of gastrointestinal bleeding. World J Gastrointest Pathophysiol. 2014;5(3):284–292. doi:10.4291/wjgp.v5.i3.284
   PubMedGoogle Scholar
• Li L, Du Y, Yin Z, et al. Preparation and the hemostatic property study of porous gelatin microspheres both in vitro and in vivo. Colloids Surf B Biointerfaces. 2020;187:110641. doi:10.1016/j.colsurfb.2019.110641
   PubMed Web of Science ®Google Scholar
• Li D, Chen J, Wang X, et al. Recent advances on synthetic and polysaccharide adhesives for biological hemostatic applications. Front Bioeng Biotechnol. 2020;8:926. doi:10.3389/fbioe.2020.00926
   PubMed Web of Science ®Google Scholar
• Pourshahrestani S, Zeimaran E, Kadri NA, et al. Polymeric hydrogel systems as emerging biomaterial platforms to enable hemostasis and wound healing. Adv Healthc Mater. 2020;9(20):2000905. doi:10.1002/adhm.202000905
   Web of Science ®Google Scholar
• Wang T, Yi W, Zhang Y, et al. Sodium alginate hydrogel containing platelet-rich plasma for wound healing. Colloids Surf B Biointerfaces. 2023;222:113096. doi:10.1016/j.colsurfb.2022.113096
   PubMed Web of Science ®Google Scholar
• Chen Z, Yao J, Zhao J, et al. Injectable wound dressing based on carboxymethyl chitosan triple-network hydrogel for effective wound antibacterial and hemostasis. Int J Biol Macromol. 2023;225:1235–1245. doi:10.1016/j.ijbiomac.2022.11.184
   PubMed Web of Science ®Google Scholar
• Kibungu C, Kondiah PPD, Kumar P, et al. This review recent advances in chitosan and alginate‐based hydrogels for wound healing application. Front Mater. 2021;8. doi:10.3389/fmats.2021.681960
   PubMed Web of Science ®Google Scholar
• Yu P, Zhong W. Hemostatic materials in wound care. Burns Trauma. 2021;9:tkab019. doi:10.1093/burnst/tkab019
   PubMed Web of Science ®Google Scholar
• Santosh Shivaji B, Jianzhong S, Yifei S, et al. Polysaccharide-based hemostats: recent developments, challenges, and future perspectives. Cellulose. 2021;28(14):8899–8937. doi:10.1007/s10570-021-04132-x
   Web of Science ®Google Scholar
• Eden C, Buonomo OC, Busch J, et al. An international multidisciplinary peer-driven consensus on the optimal use of hemostatic powders in surgical practice. Updat Surg. 2021;73(4):1267–1273. doi:10.1007/s13304-021-01136-x
   PubMed Web of Science ®Google Scholar
• Donley ER, Munakomi S, Loyd JW. Hemorrhage Control. Treasure Island (FL): StatPearls StatPearls Publishing; 2023.
   Google Scholar